Quantitation of Cannabidiol (CBD) in brain regions and plasma following intranasal administration of a CBD nanoformulation
Abstract Background and objective Delivering therapeutic drugs to the brain for neurological disorders remains challenging due to the restrictive nature of the blood–brain barrier (BBB). Intranasal (IN) nanoparticle delivery may enhance the bioavailability of lipophilic cannabidiol (CBD), addressing...
Saved in:
| Main Authors: | Gunjan Upadhyay, Oksana Fihurka, Pranav Patel, Juan Sanchez-Ramos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Cannabis Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42238-025-00308-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of cannabidiol and its main metabolites on human neural stem cells
by: Leah E. Latham, et al.
Published: (2025-06-01) -
Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice
by: Sarah A. Brendle, et al.
Published: (2025-06-01) -
Differential metabolic pathways underlie THC- and CBD-mediated inhibition of B-cell activation in both young and aged mice
by: Zhanna Yekhtin, et al.
Published: (2025-06-01) -
Cannabinoid spoilage, metabolism and cannabidiol(CBD) conversion to Tetrahydrocannabinol(THC) mechanisms with energetic parameters
by: Alwyn Henriques
Published: (2025-02-01) -
High-Performance Liquid Chromatography with DAD Detection for the Determination of Cannabinoids in Commercial Veterinary CBD Oil
by: Zehra Hajrulai-Musliu, et al.
Published: (2024-12-01)